Pay in 4 interest-free payments of $5.32 Learn more
Ships within 48 hours · Estimated delivery Jul 31 - Aug 5
The derivation from native hGH provides biological plausibility: the C-terminal region of growth hormone has been known since the 1990s to possess independent lipolytic activity separate from the growth-promoting effects mediated by intact GH and IGF-1 signaling
For that reason, we offer non-surgical treatment for joint pain that can address the pain at the source
(2000), Horm Res 53(Suppl 3), PubMed 10971106 Statistics from preclinical literature AOD-9604 = modified fragment of hGH 177191 + N-terminal Tyr (sequence Tyr-Leu-Arg-Ile-Val-Gln-Cys-Arg-Ser-Val-Glu-Gly-Ser-Cys-Gly-Phe), molecular weight 1815.1 Da Developed at Metabolic Pharmaceuticals (Australia) based on the work of professor Frank Ng (Monash University) in the 1990s Standard experimental dose in obesity clinical trials: 1 mg/day subcutaneously (Phase 2b, Heffernan et al.) Mechanism: stimulation of 3-adrenergic receptors in adipose tissue, increased lipolysis and fatty acid oxidation without activation of the hGH receptor (no IGF-1 increase) Phase 2b clinical trial (2007, 300 patients): weight reduction ~2.8 kg vs placebo over 12 weeks FDA status: NDI rejection (2014) as a dietary supplement
Half Life: 6 Days (Plasma), 12 Months (Liver)
As an injectable supplement, L-carnitine has been employed to support various health conditions, including heart and circulatory issues, as well as to enhance athletic performance
Typically it is safe for all patients and has no risk of being toxic
US$ 21.62
US$ 26.32
US$ 25.82
US$ 28.04
US$ 23.56
US$ 22.11
US$ 20.83
US$ 29.85
US$ 21.90
US$ 21.43
US$ 27.13
